Oncology

  1. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €735.00
  2. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €1,692.00
  3. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €4,389.00
  4. Lonsurf (trifluridine/tipiracil)
    Lonsurf (trifluridine/tipiracil)
    by Les Laboratoires Servier
    for Colorectal Cancer
    €852.00
  5. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €5,497.80
  6. Ninlaro (ixazomib)
    Ninlaro (ixazomib)
    by Takeda Pharma A/S
    for Multiple Myeloma
    €5,880.00
  7. Odomzo (sonidegib)
    Odomzo (sonidegib)
    by Sun Pharmaceutical Industries Europe B.V.
    for Skin Cancer
    €6,478.50
  8. Onivyde (irinotecan hydrochloride trihydrate)
    Onivyde (irinotecan hydrochloride trihydrate)
    by Baxalta Innovations GmbH
    for Pancreatic Cancer
    €984.90
  9. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €552.00
View as Grid List

Items 19-27 of 35

per page
Set Descending Direction